Investing.com - Financial Markets Worldwide
💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

UPDATE 1-Sanofi U.S. recalls Auvi-Q injections for severe allergy

Published 2015-10-28, 05:11 p/m
© Reuters. UPDATE 1-Sanofi U.S. recalls Auvi-Q injections for severe allergy
SASY
-

(Adds details)
Oct 28 (Reuters) - French drugmaker Sanofi SA SASY.PA
SNY.N said it was voluntarily recalling all its Auvi-Q
injections in the United States to treat patients with severe
allergic reactions.
The company said on Wednesday its U.S. unit was recalling
the injections as they could potentially deliver an inaccurate
dose. urn:newsml:reuters.com:*:nPn4GNvB7
Auvi-Q is designed to treat anaphylaxis, a potentially fatal
allergic reaction, in patients who are at risk or who have a
history of such reactions.
An incorrect dose could lead to significant health issues,
Sanofi said.
The company has received 26 reports of suspected device
malfunctions in the United States and Canada as of Oct. 26.
However, there has been no confirmation on the reports and
no deaths have been reported so far, Sanofi said.
The company's U.S.-listed shares closed at $51.49 on the New
York Stock Exchange on Wednesday.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.